Close menu


Sunderland Repository records the research produced by the University of Sunderland including practice-based research and theses.

Histone deacetylase inhibitors in APL and beyond.

Petrie, Kevin, Prodromou, N and Zelent, A (2007) Histone deacetylase inhibitors in APL and beyond. Current topics in microbiology and immunology, 313. pp. 157-203. ISSN 0070-217X

Item Type: Article


In recent years the study of chemical modifications to chromatin and their effects on cellular processes has become increasingly important in the field of cancer research. Disruptions to the normal epigenetic pattern of the cell can serve as biomarkers and are important determinants of cancer progression. Accordingly, drugs that inhibit the enzymes responsible for modulating these epigenetic markers, in particular histone deacetylases, are the focus of intense research and development. In this chapter we provide an overview of class I and II histone deacetylases as well as a guide to the diverse types of histone deacetylase inhibitors and their activities in the context of APL. We also discuss the rationale for the use of histone deacetylase inhibitors in combination therapy for the treatment of cancer and the current status of clinical trials.

[img] PDF
2007 Histone Deacetylase Inhibitors in APL and Beyond.pdf - Accepted Version
Restricted to Repository staff only

Download (2MB)

More Information

Depositing User: Kevin Petrie


Item ID: 12426
Identification Number:
ISSN: 0070-217X
Official URL:

Users with ORCIDS

ORCID for Kevin Petrie: ORCID iD

Catalogue record

Date Deposited: 18 Aug 2020 11:18
Last Modified: 30 Sep 2020 10:48


Author: Kevin Petrie ORCID iD
Author: N Prodromou
Author: A Zelent

University Divisions

Faculty of Health Sciences and Wellbeing > School of Medicine


Sciences > Biomedical Sciences
Sciences > Health Sciences

Actions (login required)

View Item View Item